imipramine has been researched along with Sarcoma 180 in 1 studies
Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.
Sarcoma 180: An experimental sarcoma of mice.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hoshi, A | 1 |
| Kanzawa, F | 1 |
| Kuretani, K | 1 |
1 other study available for imipramine and Sarcoma 180
| Article | Year |
|---|---|
Enhancement of antitumor activity of cyclophosphamide with imipramine.
Topics: Animals; Cyclophosphamide; Drug Stability; Drug Synergism; Female; Imipramine; Liver; Mice; Phenobar | 1969 |